Lixiang Wu

1.1k total citations
46 papers, 832 citations indexed

About

Lixiang Wu is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Lixiang Wu has authored 46 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Biomedical Engineering and 5 papers in Oncology. Recurrent topics in Lixiang Wu's work include Circular RNAs in diseases (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Plasmonic and Surface Plasmon Research (3 papers). Lixiang Wu is often cited by papers focused on Circular RNAs in diseases (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Plasmonic and Surface Plasmon Research (3 papers). Lixiang Wu collaborates with scholars based in China, Thailand and Singapore. Lixiang Wu's co-authors include Baisheng Huang, Han Yang, Kunxian Shu, Weiguo Yin, Biao Li, Qizhi Luo, Dong Huang, Qingping Tang, Lianqin Zhao and Jiayan Li and has published in prestigious journals such as Nano Letters, Neurology and Journal of Cleaner Production.

In The Last Decade

Lixiang Wu

44 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixiang Wu China 15 342 167 133 71 69 46 832
Linhao You China 16 313 0.9× 130 0.8× 127 1.0× 45 0.6× 102 1.5× 20 930
Qianying Huang China 13 318 0.9× 177 1.1× 69 0.5× 52 0.7× 40 0.6× 31 611
Krisztián Szigeti Hungary 20 372 1.1× 91 0.5× 269 2.0× 83 1.2× 130 1.9× 81 1.3k
Xiaodan Hu China 19 291 0.9× 86 0.5× 118 0.9× 30 0.4× 82 1.2× 66 956
Shuang Zou China 20 309 0.9× 81 0.5× 120 0.9× 54 0.8× 94 1.4× 57 976
Yu Tian China 23 588 1.7× 202 1.2× 174 1.3× 98 1.4× 87 1.3× 72 1.2k
Michał Fiedorowicz Poland 20 732 2.1× 271 1.6× 135 1.0× 47 0.7× 74 1.1× 51 1.5k
Bo Fan China 18 351 1.0× 100 0.6× 212 1.6× 29 0.4× 169 2.4× 36 806
Cuicui Xie China 18 267 0.8× 61 0.4× 124 0.9× 128 1.8× 41 0.6× 32 979
Wenxia Zhu China 16 263 0.8× 119 0.7× 68 0.5× 53 0.7× 134 1.9× 39 744

Countries citing papers authored by Lixiang Wu

Since Specialization
Citations

This map shows the geographic impact of Lixiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixiang Wu more than expected).

Fields of papers citing papers by Lixiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixiang Wu. The network helps show where Lixiang Wu may publish in the future.

Co-authorship network of co-authors of Lixiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixiang Wu. A scholar is included among the top collaborators of Lixiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixiang Wu. Lixiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Ke, et al.. (2024). Au/PANI@PtCu-based electrochemical immunosensor for ultrasensitive determination of pro-gastrin-releasing peptide. Microchimica Acta. 191(3). 126–126. 3 indexed citations
2.
Zhang, Fan, Lixiang Wu, Songshan Feng, et al.. (2023). FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling. CNS Neuroscience & Therapeutics. 29(11). 3351–3363. 7 indexed citations
3.
Li, Wei, Baisheng Huang, Yuanyuan Xiong, Lijian Yang, & Lixiang Wu. (2022). 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis. Cancer Cell International. 22(1). 32–32. 14 indexed citations
4.
Wu, Lixiang, et al.. (2021). TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT Pathway. Biochemical Genetics. 59(4). 1018–1032. 8 indexed citations
5.
Yang, Yuanjie, Lixiang Wu, Yidong Liu, et al.. (2020). Deuterogenic Plasmonic Vortices. Nano Letters. 20(9). 6774–6779. 49 indexed citations
6.
Li, Xin, Lixiang Wu, & Yuanjie Yang. (2019). Enhanced near field focus steering of rectangular nanoslit metasurface structure. Acta Physica Sinica. 68(18). 187103–187103. 1 indexed citations
7.
8.
Huang, Baisheng, Qizhi Luo, Han Yang, et al.. (2017). MiR‐223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway. Journal of Cellular Biochemistry. 118(10). 3452–3461. 49 indexed citations
9.
10.
Tang, Qingping, Qin Shen, Lixiang Wu, et al.. (2016). STAT3 signal that mediates the neural plasticity is involved in willed-movement training in focal ischemic rats. Journal of Zhejiang University SCIENCE B. 17(7). 493–502. 9 indexed citations
11.
Tang, Qingping, et al.. (2014). Early Sitting, Standing, and Walking in Conjunction With Contemporary Bobath Approach for Stroke Patients With Severe Motor Deficit. Topics in Stroke Rehabilitation. 21(2). 120–127. 9 indexed citations
12.
Huang, Baisheng, et al.. (2013). [Protective effect of maslinic acid preconditioning against oxygen-glucose deprivation- induced injuries in embryonic rat cortical neurons].. PubMed. 33(3). 322–5, 331. 1 indexed citations
13.
Guo, Yadong, Lagabaiyila Zha, Weitao Yan, et al.. (2013). Identification of forensically important sarcophagid flies (Diptera: Sarcophagidae) in China based on COI and period gene. International Journal of Legal Medicine. 128(1). 221–228. 29 indexed citations
14.
Xie, Ming, Yuxiang Chen, & Lixiang Wu. (2013). Preparation of Doxorubicin-Hydrochloride Nanoliposomes by Ethanol Injection-pH Gradient Method and Their Safety Evaluation. Journal of Nanoscience and Nanotechnology. 13(1). 216–221. 3 indexed citations
15.
Huang, Baisheng, et al.. (2013). microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncology Reports. 30(5). 2263–2269. 36 indexed citations
16.
Tang, Qingping, Xiaosu Yang, Qin Shen, et al.. (2013). Willed-movement training reduces motor deficits and induces a PICK1-dependent LTD in rats subjected to focal cerebral ischemia. Behavioural Brain Research. 256. 481–487. 13 indexed citations
17.
Wu, Lixiang, et al.. (2009). Intramembranous Fragment of Amyloid-β: A Potential Immunogen for Alzheimer’s Disease Immunotherapy. Neurochemical Research. 34(11). 1889–1895. 2 indexed citations
18.
Wu, Lixiang, et al.. (2009). Amyloid-Beta Associated with Chitosan Nano-Carrier has Favorable Immunogenicity and Permeates the BBB. AAPS PharmSciTech. 10(3). 900–5. 71 indexed citations
19.
Wu, Lixiang. (2008). The progress using of nano drug carrier with magnetic targeting for the treatment of hepatocellular carcinoma. Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi. 1 indexed citations
20.
Shu, Kunxian, et al.. (2006). Characterization of the human PAP1 gene and its homologue possible involvement in mouse embryonic development. Colloids and Surfaces B Biointerfaces. 52(1). 22–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linhao You Breakdown of academic impact, for papers by Qianying Huang Breakdown of academic impact, for papers by Krisztián Szigeti Breakdown of academic impact, for papers by Xiaodan Hu Breakdown of academic impact, for papers by Shuang Zou Breakdown of academic impact, for papers by Yu Tian Breakdown of academic impact, for papers by Michał Fiedorowicz Breakdown of academic impact, for papers by Bo Fan Breakdown of academic impact, for papers by Cuicui Xie Breakdown of academic impact, for papers by Wenxia Zhu
Rankless by CCL
2026